DaShenLin Pharmaceutical Group Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 12,355.07 million compared to CNY 10,492.22 million a year ago. Revenue was CNY 12,355.07 million compared to CNY 10,492.22 million a year ago.

Net income was CNY 818.33 million compared to CNY 867.06 million a year ago. Basic earnings per share from continuing operations was CNY 0.8667 compared to CNY 0.9167 a year ago. Diluted earnings per share from continuing operations was CNY 0.8083 compared to CNY 0.9167 a year ago.